This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Nrg Therapeutics Ltd. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Susan Boyd: Innovator in mPTP Inhibitors
Introduction: Susan Boyd is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for the mitochondrial permeability transition pore (mPTP). Her innovative work has the potential to impact various therapeutic areas.
Latest Patents: Susan Boyd holds 1 patent related to her invention titled "Inhibitors of mPTP." This invention pertains to compounds of formula (I) and explores various related aspects that could lead to advancements in medical treatments.
Career Highlights: Throughout her career, Susan has demonstrated a strong commitment to research and innovation. Her work at Nrg Therapeutics Ltd. has positioned her as a key player in the development of novel therapeutic agents.
Collaborations: Susan has collaborated with notable colleagues, including Andrew Tuffnell and Richard Rutter, to further enhance her research and development efforts.
Conclusion: Susan Boyd's contributions to the field of mPTP inhibitors exemplify her dedication to innovation and research. Her work continues to pave the way for future advancements in therapeutic solutions.